BETHKIS LOGO

Email

Home/Savings & Support

Chiesi CareDirect LOGO

Get started on BETHKIS (Tobramycin Inhalation Solution) with savings and support

Chiesi CareDirect is designed with the unique needs of CF patients in mind

Chiesi CareDirect is a program that helps you start, stay, and save on treatment. We’ll connect you with prescription and device access, financial assistance, and product counseling—all at no cost. If you use government-funded plans such as Medicaid, Medicare Part D, etc, you are not eligible for Chiesi CareDirect. See terms and conditions +.

Terms and Conditions

BETHKIS $0 Copay Assistance Program: is available to patients with commercial insurance. Patients pay $0 out-of-pocket costs toward their BETHKIS prescription up to a monthly maximum of $1440. To obtain this benefit, patients must be enrolled in Chiesi CareDirect® and utilize one of the network specialty pharmacies. Upon enrollment, the offer is valid for 12 months of copay assistance. Patients with primary enrollment in government-funded plans are not eligible for copay assistance.

BETHKIS Nutrition Debit Card: Patients must call 1-888-865-1222 to sign up for the $50 BETHKIS Nutrition Debit Card. For every qualifying monthly prescription of BETHKIS that Patient fills, they can receive $50 for their choice of vitamin supplements, high-calorie drinks or other nutritional food sources. This offer covers up to $300 for an entire year supply of BETHKIS. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for the Nutrition Debit Card Program. Chiesi USA reserves the right to rescind, revoke, or amend this offer without notice at any time. This offer is good only in the U.S. The Card and Program expire on 12/31/16. Patients participating in Chiesi USA’s Patient Assistance Program are not eligible.

PAP eligibility requirements:

  • Legal US resident
  • Income level within specified guidelines
  • Uninsured or underinsured
    • Commercially insured patients without prescription coverage are eligible
    • Commercially insured patients with no plan coverage for product are eligible
    • Commercially insured patients appealing plan determination are eligible (during the appeal process)
  • Patients with a Government Funded plan are not eligible for PAP (Medicare Part D, Medicaid, etc)
  • Commercially insured patients with high out-of-pocket costs are not considered eligible. Product is considered covered

To take advantage of these helpful resources, simply work with your doctor to complete and send a Service Request Form to Chiesi CareDirect.

$0 icon

Pay as little as $0 per month*

  • Eligible patients can pay as little as $0 per month

Phone icon

1-on-1 support with a personal Patient Navigator

  • Contact a personal Patient Navigator, 24 hours a day, 7 days a week

    • Get guidance on coverage, reimbursement, authorization, appeals, benefits, and more
    • Receive counseling and other resources

$50 icon

Up to $50 per month Nutrition Debit Card

  • We understand that food preferences and nutritional needs can change over time. This debit card lets you buy the food and nutritional supplements of your choice

    • Up to $50 per month is loaded onto the card every time you fill your prescription

Kits icon

Free nebulizer kits and aerosol delivery systems

  • Get free PARI LC PLUS® nebulizer kits and Vios® Aerosol Delivery System

Hands icon

Patient Assistance Program*

  • Available for qualified patients who are uninsured or underinsured and cannot afford their medication

Contact a Chiesi CareDirect Specialist with any questions

9 am to 6 pm ET, Monday–Friday

*Restrictions apply.
†Limit one card per person per month. Patients receiving Medicare, Medicaid, or that are participating in any other state federally subsidized pharmacy benefit program are not eligible for the Nutrition Debit Card Program.

About BETHKIS® (Tobramycin Inhalation Solution)

BETHKIS® (Tobramycin Inhalation Solution) is a prescription medicine for people with cystic fibrosis (CF) who have lung infection with Pseudomonas aeruginosa bacteria. BETHKIS solution contains tobramycin, an aminoglycoside antibiotic.

It is not known if BETHKIS is safe and effective in children under 6 years of age, in people who have decreased lung volume (FEV1 less than 40% predicted), in people who have lung infection with Burkholderia cepacia bacteria, or when BETHKIS is used for more than 3 on/off cycles.

Important Safety Information

Do not take BETHKIS if you are allergic to tobramycin, or any of the ingredients in BETHKIS, or to any other aminoglycoside antibiotic.

Before you take BETHKIS, tell your health care provider if you have or have had hearing problems (ringing or other noises in your ears), dizziness, kidney problems, muscle weakness such as myasthenia gravis or Parkinson’s disease, breathing problems such as wheezing, coughing or chest tightness, or have had an organ transplant. Before you take BETHKIS, tell your health care provider if you are pregnant, plan to become pregnant, are breastfeeding or plan to breastfeed. It is not known if tobramycin in BETHKIS will pass into breast milk.

Tell your health care provider about all the medicines you take. Taking BETHKIS with certain other medications can cause serious side effects. If you are taking BETHKIS, you should discuss with your healthcare provider if you should take other medicines that may harm your nervous system, kidneys or hearing, or “water pills” (diuretics) such as Edecrin® (ethacrynic acid), Lasix® (furosemide), mannitol, or urea.

BETHKIS can cause serious side effects including hearing loss or ringing in the ears (ototoxicity), worsening kidney problems (nephrotoxicity), worsening muscle weakness, harm to an unborn baby, and/or severe breathing problems (bronchospasm). Tell your healthcare provider right away if you have hearing loss or hear noises in your ears (such as ringing or hissing), develop vertigo, dizziness, difficulty with balance, shortness of breath with wheezing, or coughing and chest tightness. Your healthcare provider may do a blood test and urine test to check how your kidneys are working while you are taking BETHKIS.

The most common side effects of BETHKIS include worsening of lung problems (decreased FEV), noisy breathing (rales), abnormal red blood cell sedimentation rate (determined by a blood test), and changes in your voice (hoarseness). Tell your health care provider about any side effect that bothers you or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Patient Information within the accompanying full Prescribing Information.

This website is intended for United States residents only.
References available upon request.

Terms and Conditions

BETHKIS $0 Copay Assistance Program: is available to patients with commercial insurance. Patients pay $0 out-of-pocket costs toward their BETHKIS prescription up to a monthly maximum of $1440. To obtain this benefit, patients must be enrolled in Chiesi CareDirect® and utilize one of the network specialty pharmacies. Upon enrollment, the offer is valid for 12 months of copay assistance. Patients with primary enrollment in government-funded plans are not eligible for copay assistance.

BETHKIS Nutrition Debit Card: Patients must call 1-888-865-1222 to sign up for the $50 BETHKIS Nutrition Debit Card. For every qualifying monthly prescription of BETHKIS that Patient fills, they can receive $50 for their choice of vitamin supplements, high-calorie drinks or other nutritional food sources. This offer covers up to $300 for an entire year supply of BETHKIS. Patients receiving Medicare, Medicaid, or that are participating in any other state or federally subsidized pharmacy benefit program are not eligible for the Nutrition Debit Card Program. Chiesi USA reserves the right to rescind, revoke, or amend this offer without notice at any time. This offer is good only in the U.S. The Card and Program expire on 12/31/16. Patients participating in Chiesi USA’s Patient Assistance Program are not eligible.

PAP eligibility requirements:
  • Legal US resident
  • Income level within specified guidelines
  • Uninsured or underinsured
    • Commercially insured patients without prescription coverage are eligible
    • Commercially insured patients with no plan coverage for product are eligible
    • Commercially insured patients appealing plan determination are eligible (during the appeal process)
  • Patients with a Government Funded plan are not eligible for PAP (Medicare Part D, Medicaid, etc)
  • Commercially insured patients with high out-of-pocket costs are not considered eligible. Product is considered covered

Are you a patient, caregiver, or healthcare professional?

I AM A PATIENT/CAREGIVER

- or -

I AM A HEALTHCARE PROFESSIONAL

The page you requested is intended for US healthcare professionals only.

Click "CONTINUE" to proceed as requested or click

"CANCEL" to remain on this page.

CONTINUECANCEL

Send this site to a friend

Someone you know may be interested in learning more about BETHKIS® (Tobramycin Inhalation Solution). Simply complete all fields below and then submit to share this information.

Recipient's name

Recipient's email

Your name

Your email

The following message will be sent to the recipient:

Dear [NAME],

I thought you may be interested in learning more about a condition called cystic fibrosis (CF) with Pseudomonas aeruginosa bacteria and a treatment that can help— BETHKIS® (Tobramycin Inhalation Solution).

What makes BETHKIS different is its concentrated formulation. BETHKIS delivers the same amount of antibiotic as other available nebulized tobramycin products (300 mg) in only 4 mL. The approximate administration time is 15 minutes.

The most common side effects of BETHKIS include worsening of lung problems, noisy breathing, abnormal red blood cell sedimentation rate (determined by a blood test), and changes in your voice (hoarseness).

You can learn more about this treatment at www.bethkis.com.

About BETHKIS® (Tobramycin Inhalation Solution)

BETHKIS® (Tobramycin Inhalation Solution) is a prescription medicine for people with cystic fibrosis (CF) who have lung infection with Pseudomonas aeruginosa bacteria. BETHKIS solution contains tobramycin, an aminoglycoside antibiotic.

It is not known if BETHKIS is safe and effective in children under 6 years of age, in people who have decreased lung volume (FEV1 less than 40% predicted), in people who have lung infection with Burkholderia cepacia bacteria, or when BETHKIS is used for more than 3 on/off cycles.


Important Safety Information

Do not take BETHKIS if you are allergic to tobramycin, or any of the ingredients in BETHKIS, or to any other aminoglycoside antibiotic.

Before you take BETHKIS, tell your health care provider if you have or have had hearing problems (ringing or other noises in your ears), dizziness, kidney problems, muscle weakness such as myasthenia gravis or Parkinson’s disease, breathing problems such as wheezing, coughing or chest tightness, or have had an organ transplant. Before you take BETHKIS, tell your health care provider if you are pregnant, plan to become pregnant, are breastfeeding or plan to breastfeed. It is not known if tobramycin in BETHKIS will pass into breast milk.

Tell your health care provider about all the medicines you take. Taking BETHKIS with certain other medications can cause serious side effects. If you are taking BETHKIS, you should discuss with your healthcare provider if you should take other medicines that may harm your nervous system, kidneys or hearing, or “water pills” (diuretics) such as Edecrin® (ethacrynic acid), Lasix® (furosemide), mannitol, or urea.

BETHKIS can cause serious side effects including hearing loss or ringing in the ears (ototoxicity), worsening kidney problems (nephrotoxicity), worsening muscle weakness, harm to an unborn baby, and/or severe breathing problems (bronchospasm). Tell your healthcare provider right away if you have hearing loss or hear noises in your ears (such as ringing or hissing), develop vertigo, dizziness, difficulty with balance, shortness of breath with wheezing, or coughing and chest tightness. Your healthcare provider may do a blood test and urine test to check how your kidneys are working while you are taking BETHKIS.

The most common side effects of BETHKIS include worsening of lung problems (decreased FEV), noisy breathing (rales), abnormal red blood cell sedimentation rate (determined by a blood test), and changes in your voice (hoarseness). Tell your health care provider about any side effect that bothers you or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Patient Information within the accompanying full Prescribing Information.

This website is intended for United States residents only.

BETHKIS® is a registered trademark of Chiesi Farmaceutici, S.p.A.
©2015 Chiesi USA, Inc. All rights reserved.
Created in the USA. B-Q315-08